What defines an adequate reading with the FreeStyle Libre continuous glucose monitoring system for adults with type 1 or type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Defines an Adequate Reading with FreeStyle Libre

For FreeStyle Libre to provide clinically useful data, you need a minimum of 14 days of continuous wear with at least 70% active sensor time (approximately 10 days of actual data collection). 1, 2

Minimum Data Requirements

Duration and Active Time:

  • Wear the sensor for at least 14 consecutive days to capture reliable glycemic patterns 1, 2
  • Maintain ≥70% active CGM time during this period, which translates to approximately 10 days of usable data 1, 2
  • This 14-day/70% threshold is the international consensus standard for all CGM systems, including FreeStyle Libre 1

Scanning Frequency:

  • Scan the FreeStyle Libre sensor at minimum once every 8 hours to capture complete 24-hour glucose data 3
  • More frequent scanning (mean 11.3 scans/day in clinical studies) provides better pattern recognition and improved outcomes 4
  • The device stores 8 hours of glucose data; scanning less frequently results in data loss 3

Understanding Sensor Accuracy Across Its Lifespan

Accuracy varies significantly by sensor age:

  • Days 0-1: Mean accuracy (MARD) of 14.5% - this is the least accurate period 5
  • Days 5-7: Mean accuracy improves to 7.8% - this is the most accurate period 5
  • Days 13-14: Mean accuracy returns to 14.7% - accuracy declines again at sensor end-of-life 5

Clinical accuracy remains acceptable throughout:

  • Only 1.9% of readings fall into potentially dangerous zones (Clarke error grid zones C, D, or E) during days 0-1 5
  • This drops to 0.2% during days 5-7 and 0.4% during days 13-14 5
  • Overall MARD of 8.9% makes FreeStyle Libre 3 more accurate than competing systems like Dexcom G7 (13.6% MARD) 6

Essential Metrics for Adequate Assessment

Once you have sufficient data (14 days, ≥70% active time), evaluate these standardized metrics:

Time in Range (TIR):

  • Target >70% of readings between 70-180 mg/dL (3.9-10.0 mmol/L) for most adults with diabetes 1, 2
  • Each 5% increase in TIR provides clinically significant benefits 1, 2

Time Below Range (TBR):

  • Target <4% total time below 70 mg/dL 1, 2
  • Specifically: <1% below 54 mg/dL (level 2 hypoglycemia) 1, 2

Time Above Range (TAR):

  • Target <25% total time above 180 mg/dL 1, 2
  • Minimize time above 250 mg/dL (level 2 hyperglycemia) 1, 2

Glycemic Variability:

  • Coefficient of variation (CV) should be ≤36% 1, 2
  • Lower CV targets (<33%) provide additional hypoglycemia protection for insulin users 1, 2

Special Population Considerations

For older adults or high-risk individuals, adequate readings require modified targets:

  • TIR >50% (≥12 hours/day) in range 70-180 mg/dL 1, 2
  • TBR <1% (<15 minutes/day) below 70 mg/dL 1, 2
  • TAR <10% (<2 hours, 24 minutes/day) above 250 mg/dL 1, 2

For pregnant individuals:

  • Use tighter target range of 63-140 mg/dL (3.5-7.8 mmol/L) 1
  • FreeStyle Libre shows good accuracy in gestational diabetes with overall MARD of 14.07% 7

Critical Limitations in Specific Populations

Use with extreme caution or avoid in advanced kidney disease:

  • In hemodialysis patients, FreeStyle Libre accuracy drops significantly with MARD of 18.2% overall and 22.8% during dialysis 1
  • Only 49-51% of readings fall into acceptable error grid zones A and B in hemodialysis patients 1
  • The glucose oxidase-based technology in FreeStyle Libre is susceptible to interference from substances in kidney disease 1
  • Do not use FreeStyle Libre in peritoneal dialysis patients - icodextrin interferes with glucose oxidase sensors 1

Common Pitfalls to Avoid

Insufficient data collection:

  • Never make treatment decisions based on less than 14 days of data with <70% active time 1, 2
  • Gaps in sensor wear reduce clinical value and limit ability to identify patterns 3

Ignoring sensor age effects:

  • Be aware that readings during the first 24 hours and last 24 hours are less accurate 5
  • Consider inserting a new sensor before removing the old one to avoid data gaps 3

Focusing only on mean glucose:

  • Mean glucose alone misses critical information about hypoglycemia and variability 2
  • Always evaluate the complete set of 10 standardized CGM metrics 1, 2

Medication and substance interference:

  • Salicylic acid and ascorbic acid can affect FreeStyle Libre accuracy 1
  • Acetaminophen does not interfere with FreeStyle Libre (unlike some other CGM systems) 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.